Health Care & Life Sciences » Pharmaceuticals | Shandong Xinhua Pharmaceutical Co. Ltd.

Shandong Xinhua Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Shandong Xinhua Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Small Cap Series
1,378,000
0.71%
187,200
0.01%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
1,071,200
0.55%
65,000
0%
04/30/2018
eQ Kehittyvae Aasia
1,040,000
0.53%
-252,200
1.2%
03/29/2018
774,800
0.4%
23,400
0.28%
06/30/2018
SPDR MSCI ACWI IMI ETF
137,800
0.07%
0
0.07%
09/06/2018
CREF Stock Account
122,200
0.06%
0
0%
03/31/2018
iShares III Plc - MSCI Emerging Markets Small Cap
122,200
0.06%
0
0.02%
09/05/2018
DFA TA World (ex-US) Core Equity Portfolio
83,200
0.04%
0
0%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
70,200
0.04%
0
0%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
67,600
0.04%
0
0%
04/30/2018

About Shandong Xinhua Pharmaceutical Co.

View Profile
Address
No. 1 Lutai Avenue
Zibo Shandong 255086
China
Employees -
Website http://www.xhzy.com
Updated 07/08/2019
Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.